| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Immunobiology, DNAX Research Institute, Palo Alto, CA 94304;
Department of Pediatrics and Biomedical Research Center, Heinrich Heine University, Düsseldorf, Germany
IL-7 is a stromal cell-derived cytokine with a well-established physiologic role in lymphocyte biology. This report describes an unexpected role for IL-7 in the development of colitis in a T and B cell-deficient environment. Recombination-activating gene-2 (RAG-2)-deficient mice (RAG-2-/-) were exposed to and subsequently maintained a horizontally transmitted microbial flora that included Helicobacter hepaticus. These animals mounted a strong myeloid cell response and developed both systemic and local signs of a severe colitis. A striking infiltration of F4/80 and MHC class II-positive cells was seen in the colon and cecum of animals undergoing the disease. Mice mutant for both IL-7 and RAG-2 (IL-7/RAG-2-/-) that were colonized by the same flora showed no signs of myeloid responses or colitis, indicating that IL-7 plays a critical role in exacerbating a non-T cell/non-B cell-mediated chronic inflammatory response. Recombinant IL-10 protein therapy was able to prevent the occurrence of colitis in susceptible mice, suggesting a pivotal role for macrophages. The implications of a role for IL-7 in this disease model with respect to human inflammatory bowel disease are discussed.
This article has been cited by other articles:
|
|
 |
|
  E. A. B. Kelly, C. J. Koziol-White, K. J. Clay, L. Y. Liu, M. E. Bates, P. J. Bertics, and N. N. Jarjour Potential Contribution of IL-7 to Allergen-Induced Eosinophilic Airway Inflammation in Asthma J. Immunol., February 1, 2009; 182(3): 1404 - 1410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Watanabe, V. P. Rao, T. Poutahidis, B. H. Rickman, M. Ohtani, S. Xu, A. B. Rogers, Z. Ge, B. H. Horwitz, T. Fujioka, et al. Cytotoxic-T-Lymphocyte-Associated Antigen 4 Blockade Abrogates Protection by Regulatory T Cells in a Mouse Model of Microbially Induced Innate Immune-Driven Colitis Infect. Immun., December 1, 2008; 76(12): 5834 - 5842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, B. H. Rickman, T. Poutahidis, K. Schlieper, E. A. Jackson, S. E. Erdman, J. G. Fox, and B. H. Horwitz c-Rel Is Essential for the Development of Innate and T Cell-Induced Colitis J. Immunol., June 15, 2008; 180(12): 8118 - 8125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Churchman and F. Ponchel Interleukin-7 in rheumatoid arthritis Rheumatology, June 1, 2008; 47(6): 753 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ramsey, M. P. Rubinstein, D. M. Kim, J.-H. Cho, J. Sprent, and C. D. Surh The Lymphopenic Environment of CD132 (Common {gamma}-Chain)-Deficient Hosts Elicits Rapid Homeostatic Proliferation of Naive T Cells via IL-15 J. Immunol., April 15, 2008; 180(8): 5320 - 5326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Tomczak, S. E. Erdman, A. Davidson, Y. Y. Wang, P. R. Nambiar, A. B. Rogers, B. Rickman, D. Luchetti, J. G. Fox, and B. H. Horwitz Inhibition of Helicobacter hepaticus-Induced Colitis by IL-10 Requires the p50/p105 Subunit of NF-{kappa}B J. Immunol., November 15, 2006; 177(10): 7332 - 7339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. de Latour, H. C. Dujardin, F. Mishellany, O. Burlen-Defranoux, J. Zuber, R. Marques, J. Di Santo, A. Cumano, P. Vieira, and A. Bandeira Ontogeny, function, and peripheral homeostasis of regulatory T cells in the absence of interleukin-7 Blood, October 1, 2006; 108(7): 2300 - 2306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Erdman, V. P. Rao, T. Poutahidis, M. M. Ihrig, Z. Ge, Y. Feng, M. Tomczak, A. B. Rogers, B. H. Horwitz, and J. G. Fox CD4+CD25+ Regulatory Lymphocytes Require Interleukin 10 to Interrupt Colon Carcinogenesis in Mice Cancer Res., September 15, 2003; 63(18): 6042 - 6050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Tomczak, S. E. Erdman, T. Poutahidis, A. B. Rogers, H. Holcombe, B. Plank, J. G. Fox, and B. H. Horwitz NF-{kappa}B Is Required Within the Innate Immune System to Inhibit Microflora-Induced Colitis and Expression of IL-12 p40 J. Immunol., August 1, 2003; 171(3): 1484 - 1492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Erdman, T. Poutahidis, M. Tomczak, A. B. Rogers, K. Cormier, B. Plank, B. H. Horwitz, and J. G. Fox CD4+ CD25+ Regulatory T Lymphocytes Inhibit Microbially Induced Colon Cancer in Rag2-Deficient Mice Am. J. Pathol., February 1, 2003; 162(2): 691 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Maloy, L. Salaun, R. Cahill, G. Dougan, N. J. Saunders, and F. Powrie CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent Mechanisms J. Exp. Med., January 6, 2003; 197(1): 111 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Burich, R. Hershberg, K. Waggie, W. Zeng, T. Brabb, G. Westrich, J. L. Viney, and L. Maggio-Price Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice Am J Physiol Gastrointest Liver Physiol, September 1, 2001; 281(3): G764 - G778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. V. Solnick and D. B. Schauer Emergence of Diverse Helicobacter Species in the Pathogenesis of Gastric and Enterohepatic Diseases Clin. Microbiol. Rev., January 1, 2001; 14(1): 59 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Dieleman, A. Arends, S. L. Tonkonogy, M. S. Goerres, D. W. Craft, W. Grenther, R. K. Sellon, E. Balish, and R. B. Sartor Helicobacter hepaticus Does Not Induce or Potentiate Colitis in Interleukin-10-Deficient Mice Infect. Immun., September 1, 2000; 68(9): 5107 - 5113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. B. Young, K. A. Knox, and D. B. Schauer Cytolethal Distending Toxin Sequence and Activity in the Enterohepatic Pathogen Helicobacter hepaticus Infect. Immun., January 1, 2000; 68(1): 184 - 191. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
